<DOC>
	<DOCNO>NCT00441766</DOCNO>
	<brief_summary>This study explore safety effectiveness different dos AGN 203818 relieve Irritable Bowel Syndrome pain . The study conduct 2 part . Part A enrolled 213 pt dose either 3 , 20 , 60 mg AGN 203818 placebo 4 week treatment duration . Part B enroll 320 pt dose either 60 , 100 , 160 mg BID AGN 203818 placebo 12 week treatment duration .</brief_summary>
	<brief_title>Safety Efficacy Oral AGN 203818 Relief Irritable Bowel Syndrome Pain</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Diagnosis Irritable Bowel Syndrome Moderate severe IBS pain Any uncontrolled disease Pregnant nursing female</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>